Company intelligence / Profile preview

Anonymous

Alimos, Attica, Greeceanonymoushackers.net ↗

Ownership: Private
Development stage: Phase 2

Overview

Famar is an established European contract manufacturing and development organization serving the pharmaceutical and healthcare industries. With over 70 years of experience, it provides flexible solutions from drug development to commercial production for finished dosage forms. The company offers analytical development, formulation development, ICH stability testing, and process development services for small molecule drugs in various formats including liquids and sterile products[1].

Modalities: Small moleculesFinished dosage forms (liquids, lyophilized ampoules/vials, semi-solids, solids, sterile ampoules, sterile vials)
Industry: Contract Manufacturing Organization

Drug pipeline

4 assets

WVE-006

Clinical

Indications: Alpha-1 antitrypsin deficiency

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Anonymous.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anonymous.

Explore the full profile